Alternatives to Upstream Bio

AI-driven digital twin of embryo development for cell-based therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Compressing biology to develop the next generation of therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Developing novel therapeutic approaches for ocular diseases.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.